Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal

Suzano and Kimberly-Clark Form $3.4B Global Tissue Joint Venture

June 5, 2025

Consumer Products

Suzano and Kimberly-Clark announced the creation of a $3.4 billion global tissue joint venture operating in more than 70 countries. Suzano will acquire a 51% stake at closing, paying Kimberly-Clark $1.734 billion in cash, while Kimberly-Clark holds 49% and retains U.S. consumer tissue and professional businesses.

Alcon Acquires EYSUVIS and INVELTYS Commercial Portfolio from Kala Pharmaceuticals

May 23, 2022

Pharmaceuticals

Alcon Inc. agreed to acquire the commercial portfolio and related intellectual property for EYSUVIS and INVELTYS from Kala Pharmaceuticals for an upfront payment of $60 million, with Kala eligible for future commercial milestone payments. The asset sale allows Alcon to expand its ophthalmic drug franchises while enabling Kala to focus on its pipeline (KPI-012) and extend its cash runway.

Cinven Acquires Bayer Environmental Science Professional (Envu)

March 10, 2022

Environmental Services

International private equity firm Cinven has acquired Bayer's Environmental Science Professional business for $2.6 billion. The carved-out business, headquartered in Cary, North Carolina and operating as Envu with nearly 900 employees, will run as an independent platform focused on pest management, vector control and vegetation management while Bayer uses proceeds to reduce net debt.

Fresenius Kabi Acquires Ivenix

March 31, 2022

Medical Devices

Ivenix, Inc. has entered into a definitive agreement to be acquired by Fresenius Kabi for an upfront payment of $240 million plus additional milestone payments. The deal brings Ivenix's next-generation infusion pump technology and software together with Fresenius Kabi's IV fluids and infusion therapy portfolio to create a comprehensive infusion offering and accelerate U.S. commercial expansion.

Merck to Acquire Verona Pharma for Approximately $10 Billion

July 9, 2025

Pharmaceuticals

Merck, through a subsidiary, entered into a definitive agreement to acquire Verona Pharma in a transaction valued at approximately $10 billion (at $107 per ADS). The acquisition is intended to add Ohtuvayre (ensifentrine) to Merck’s cardio-pulmonary pipeline, following FDA approval for COPD in June 2024.

Sonoco Acquires Eviosys from KPS for $3.9 Billion

June 26, 2024

Packaging

Sonoco Products Company has agreed to acquire Eviosys, a leading European metal-packaging manufacturer, from KPS Capital Partners for approximately $3.9 billion. The deal, which also involves Crown Holdings selling its remaining ~20% stake, creates a global leader in metal food can and aerosol packaging and is intended to scale Sonoco’s core metal packaging platform and capture operational synergies.